Scopia Capital Management L.P., 10% Owner at ACORDA THERAPEUTICS INC (ACOR), sold 105,782 shares at $14.99 ($1.6M) on 2018-12-28, disclosed to the SEC on 2019-01-02.
Open-market sale of $1.6M ACOR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.99 | 52,891 | $793K | 50.0% |
| 2 | $14.99 | 52,891 | $793K | 50.0% |
| Total | $14.99 avg | 105,782 | $1.6M | 100% |
| Filing → |
| ITRI | SELL | 2019-05-03 | $7.4M | — | Filing → |
| ITRI | SELL | 2019-05-01 | $4.4M | — | Filing → |
| ITRI | SELL | 2019-04-22 | $1.4M | — | Filing → |